MP Astrazeneca says the failed Freeman bid for George Freeman is not a lost opportunity . Different companies are responding to this challenge in different ways . Instead , it ensures a focus on the crusade to make the UK a hub for medicine design . Pfizer says the UK must look to its public health service to boost research . That will ensure the debate continues to be around doing business in the UK .
MP Astrazeneca says the failed Freeman bid for George Freeman is not a lost opportunity . Instead , it ensures a focus on the crusade to make the UK a hub for medicine design . Pfizer says the UK must look to its public health service to boost research . That will ensure the debate continues to be around doing business in the UK .